Latest 杨贵妃传媒視頻 Health News Stories
杨贵妃传媒視頻 Health News' 'What the Health?': Congress Punts to a Looming Lame-Duck Session
Congress left Washington for the campaign trail this week, but not before approving a spending bill that expires shortly before Christmas. Lawmakers will be busy after the election working on not just the legislation needed to keep the government running, but also several health programs set to expire. Meanwhile, Republicans continue to downplay abortion as Democrats press it as a campaign issue. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Joanne Kenen of Johns Hopkins University and Politico join 杨贵妃传媒視頻 Health News chief Washington correspondent Julie Rovner to discuss these stories and more.
杨贵妃传媒視頻 Health News' 'What the Health?': American Health Under Trump 鈥 Past, Present, and Future
Dreaming of a Trump victory, Republicans have a wish list of health policy changes 鈥 including loosening Affordable Care Act regulations to make cheaper coverage available and ending Medicare drug price negotiations. Meanwhile, after a publicly reported death stemming from a state abortion ban, Vice President Kamala Harris is emphasizing the consequences of Trump鈥檚 work to overturn Roe v. Wade. Tami Luhby of CNN, Shefali Luthra of The 19th, and Joanne Kenen of Politico and Johns Hopkins University join 杨贵妃传媒視頻 Health News senior editor Emmarie Huetteman to discuss these stories and more.
Harris and Trump Are Ready To Take on Big Pharma
Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars this election season. When Harris was California鈥檚 attorney general, she joined cases that resulted in almost $7.2 billion (about $22 per person in the United […]
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
Para las farmac茅uticas, la pelea entre Trump y Harris es entre dos enemigos de la industria
Legisladores de ambos partidos atacan cada vez m谩s a la industria, por los precios de los medicamentos que la mayor铆a de los estadounidenses consideran irrazonables.
Since Fall of ‘Roe,’ Self-Managed Abortions Have Increased
The percentage of people who say they鈥檝e tried to end a pregnancy without medical assistance increased after “Roe v. Wade” was overturned. One of the most common reasons for seeking a self-managed abortion was privacy concerns.
Copycat Weight-Loss Drugs Are Major Players With Consumers
As many as 1 in 8 American adults has tried one of the GLP-1 anti-obesity drugs, but a surprising number aren鈥檛 getting their supplies from pharma giants Novo Nordisk or Eli Lilly. Up to 30 percent of the market, by some estimates, is made up of copycat versions from compounding pharmacies. Compounding is legal, though […]
杨贵妃传媒視頻 Health News' 'What the Health?': Harris in the Spotlight
For the 2024 campaign, Joe Biden is out, and Kamala Harris is in. As the vice president makes moves toward the top of the Democratic presidential ticket, health policy is resurging as a campaign issue. Meanwhile, Congress tries 鈥 and again fails 鈥 to make timely progress on the annual government spending bills as abortion issues cause delays. Alice Miranda Ollstein of Politico, Stephanie Armour of 杨贵妃传媒視頻 Health News, and Rachel Cohrs Zhang of Stat join 杨贵妃传媒視頻 Health News鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Anthony Wright, the new executive director of Families USA, about his plans for the organization and his history working with Harris on health topics.鈥
World-Famous Wall Drug Isn鈥檛 Immune From Challenges Facing Rural Pharmacies
Even as part of a popular South Dakota tourist attraction, an independent pharmacy serving locals, remote ranchers, and sightseers struggles with staffing and insurer payments.
Louisiana Reclassifies Drugs Used in Abortions as Controlled Dangerous Substances
Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state鈥檚 list of controlled dangerous substances, a move that has alarmed doctors in the state.
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma鈥檚 Weight Loss Drugs
Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.
Qu茅 son los medicamentos compuestos que millones de personas usan para bajar de peso
La FDA permite e incluso fomenta que las farmacias de compuestos produzcan y vendan copias cuando un medicamento est谩 en escasez, como es el caso de las drogas para combatir el sobrepeso y la obesidad.
Harris, alguna vez la voz de Biden sobre el aborto, tendr铆a un enfoque abierto en temas de salud
Mientras los dem贸cratas reconstruyen su candidatura presidencial a pocos meses de las elecciones, se esperar铆a que, de ser la nueva nominada, Harris adoptase una postura agresiva en apoyo al acceso al aborto y en otros temas controversiales de salud.
Harris, Once Biden鈥檚 Voice on Abortion, Would Take an Outspoken Approach to Health
If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access 鈥 hitting former President Donald Trump on an issue that could undermine his chances of victory.
The Supreme Court Just Limited Federal Power. Health Care Is Feeling the Shockwaves.
A Supreme Court ruling restricting federal power will likely have seismic ramifications for health policy. A flood of litigation 鈥 with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations they say are too expensive or burdensome and not authorized by law 鈥 could leave the country with a patchwork of disparate health regulations.
杨贵妃传媒視頻 Health News' 'What the Health?': SCOTUS Rejects Abortion Pill Challenge 鈥 For Now聽
The Supreme Court has dismissed a challenge to the FDA鈥檚 approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of 杨贵妃传媒視頻 Health News, and Emmarie Huetteman of 杨贵妃传媒視頻 Health News join 杨贵妃传媒視頻 Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF鈥檚 new 鈥淗ealth Policy 101鈥 primer.
Biden Plan To Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say
President Joe Biden is campaigning for reelection on his efforts to cut costs for Medicare patients at the pharmacy counter. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.
Weight-Loss Drugs Are So Popular They鈥檙e Headed for Medicare Negotiations
The steep prices 鈥 and popularity 鈥 of Ozempic and similar weight-loss and diabetes drugs could soon make them a priority for Medicare drug price negotiations. List prices for a month鈥檚 supply of the drugs range from $936 to $1,349, according to the Peterson-杨贵妃传媒視頻 Health System Tracker. The Inflation Reduction Act President Biden signed in […]
Readers Issue Rx for Clogged ERs and Outrageous Out-of-Pocket Costs
杨贵妃传媒視頻 Health News gives readers a chance to comment on a recent batch of stories.
Journalists Talk Cost of Weight Loss Drugs and Lack of Obesity Doctors to Manage Their Use
杨贵妃传媒視頻 Health News and California Healthline staff made the rounds on national and local media this week to discuss topical stories. Here鈥檚 a collection of their appearances.
